IQVIA CEO to Address Leerink Healthcare Conference Amid Data Privacy Scrutiny

  • IQVIA CEO Ari Bousbib will speak at the Leerink Partners 2026 Global Healthcare Conference on March 9, 2026.
  • The presentation will be webcast live at 9:20 a.m. ET.
  • IQVIA is a global provider of clinical research, commercial insights, and healthcare intelligence.
  • The company employs approximately 93,000 people across over 100 countries.

IQVIA's participation in the Leerink conference underscores the ongoing importance of investor communication within the healthcare intelligence sector. The company's focus on AI and data privacy highlights the growing tension between innovation and regulatory compliance, a challenge facing all major players in the life sciences industry. IQVIA's scale—with nearly $15 billion in annual revenue—means its practices and disclosures have outsized influence on industry standards.

Data Governance
Increased regulatory scrutiny surrounding patient data privacy will likely be a focal point of Bousbib’s remarks, given IQVIA’s emphasis on data handling and AI applications.
AI Adoption
The company’s ability to maintain trust and compliance while scaling its AI-powered capabilities will be critical for sustaining growth and avoiding regulatory pushback.
Growth Trajectory
The pace at which IQVIA can integrate its various data and technology solutions will determine its ability to maintain its competitive advantage in a rapidly evolving market.